Micrima Logo 3D cmyk REG.png


Micrima has developed a non-invasive and non-ionising radio wave technology for detecting breast cancer.

Micrima's MARIA system received European regulatory approval in 2015, and has been trialled on over 400 women in the UK. It is currently trialling in European centres.

Micrima has received a total of $18.8 million investment from Technology Venture Partners, Angel CoFund and Venture Founders.